Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, April 14, 2026.
Coherus Oncology, Inc. (NASDAQ:CHRS)
Crossroads (+60) - CHRS is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid CHRS?
MarketClub looks at technical strength and momentum to determine if the timing is right for CHRS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CHRS
The long-term trend has been UP since Aug 22nd, 2025 at 1.150
The intermediate-term trend has been DOWN since Mar 19th, 2026 at 1.570
The short-term trend has been DOWN since Apr 7th, 2026 at 1.665
Smart Scan Analysis for CHRS
Based on our trend formula, CHRS is rated as a +60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 1.670 | 1.710 | 1.620 | 1.705 | +0.025 |
| Prev. Close | Volume | Bid | Ask | Time |
| 1.680 | 852295 | 2026-04-13 15:59:39 |
| Year High | 20.662 | Year High Date | 2018-08-28 |
| Year Low | 8.55 | Year Low Date | 2018-03-08 |
| 52wk High | 2.6158 | 52wk High Date | 2026-01-27 |
| 52wk Low | 0.71 | 52wk Low Date | 2025-06-23 |
| Average Volume | 1,134,476 | Shares Outstanding | 149,890 |
| Assets | 258,343,000M | Liabilities | 197,329,000M |
| P/E Ratio | 1.1748 | Volatility | 89.13 |